Sort
40,608 grants matching “prostate cancer”
HSCT-CHESS to Enhance Hematopoietic Transplant Recovery
$551,345Susan Kenyon Parsons · Tufts Medical Center · R01 · FY2010 · CA
Control of Protein Translation in Cancer Pathogenesis
$551,327Sloan-Kettering Institute For Cancer Res · U01 · FY2005 · CA
ABERRANT EXPRESSION OF PROTEIN PHOSPHATASES DURING ANDROGEN-INDEPENDENT GROWTH IN HUMAN PROSTATE CANCER CELLS.
$551,250Board Of Regents Of The University Of Nebraska · · FY2008 · Department of the Army
CONNEXINS IN PROSTATE CANCER INITIATION AND PROGRESSION
$551,250Board Of Regents Of The University Of Nebraska · · FY2009 · Department of the Army
ABERRANT EXPRESSION OF PROTEIN PHOSPHATASES DURING ANDROGEN-INDEPENDENT GROWTH IN HUMAN PROSTATE CANCER CELLS
$551,250Board Of Regents Of The University Of Nebraska · · FY2008 · Department of the Army
NEW APPLICATIONS OF THE PROSTATE CANCER MARKER PSA
$551,249University Of Washington · P50 · FY2001 · DK
NEW APPLICATIONS OF THE PROSTATE CANCER MARKER PSA
$551,249University Of Washington · P50 · FY2002 · DK
NEW APPLICATIONS OF THE PROSTATE CANCER MARKER PSA
$551,249University Of Washington · P50 · FY2000 · DK
Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling
$551,182Ashish A. Deshmukh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · CA
Development of statistical genetics methodology
$551,144Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2013 · HG
High Intensity Ultrasound for Prostate Treatment
$551,118Interscience Research, Inc. · R44 · FY2002 · CA
Natural History of Prostatism: The Olmsted County Study
$551,055Jennifer Lynn St Sauver · Mayo Clinic Rochester · R01 · FY2009 · DK
Predicting Prostate Cancer Aggressiveness
$550,965Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2015 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$550,926Marcus W Bosenberg · Yale University · R01 · FY2016 · CA
Tumor selective inhibition of the WNT pathway
$550,824Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Genetic determinants of gene expression phenotypes in aggressive prostate cancer
$550,809Liang Wang · Medical College Of Wisconsin · R01 · FY2016 · CA
In vivo effects of sulforaphane supplementation on normal human prostate
$550,777Daniel W Lin · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
MECHANISTIC STUDIES OF OLIGONUCLEOTIDE APTAMERS WITH POTENT ANTIPROLIFERATIVE AND PRO-APOPTIC ACTIVITY AGAINST PROSTATE CANCER CELLS
$550,771University Of Louisville · · FY2008 · Department of Defense
Nitric Oxide as a Modifier of Oxidative Stress
$550,707David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Targeting angiotensin and inflammation to prevent radiotherapy-induced bladder toxicity.
$550,549Brian Marples · University Of Rochester · R01 · FY2025 · CA
MCG Minority-Based Community Clinical Oncology Program
$550,477Anand P Jillella · Augusta University · U10 · FY2009 · CA
MCG Minority-Based Community Clinical Oncology Program
$550,477Anand P Jillella · Augusta University · U10 · FY2008 · CA
NEUROD1 function in SCLC fate and plasticity
$550,323Trudy Gale Oliver · Duke University · R01 · FY2024 · CA
Racial Differences in Prostate Cancer Molecular Subtyping
$550,313Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Community-based Navigator Program for Cancer Control in African Americans
$550,291Jerry Calvin Johnson · University Of Pennsylvania · R01 · FY2011 · CA